WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity

S Becker-Herman, A Meyer-Bahlburg… - Journal of Experimental …, 2011 - rupress.org
S Becker-Herman, A Meyer-Bahlburg, MA Schwartz, SW Jackson, KL Hudkins, C Liu
Journal of Experimental Medicine, 2011rupress.org
Patients with the immunodeficiency Wiskott-Aldrich syndrome (WAS) frequently develop
systemic autoimmunity. Here, we demonstrate that mutation of the WAS gene results in B
cells that are hyperresponsive to B cell receptor and Toll-like receptor (TLR) signals in vitro,
thereby promoting a B cell–intrinsic break in tolerance. Whereas this defect leads to
autoantibody production in WAS protein–deficient (WASp−/−) mice without overt disease,
chimeric mice in which only the B cell lineage lacks WASp exhibit severe autoimmunity …
Patients with the immunodeficiency Wiskott-Aldrich syndrome (WAS) frequently develop systemic autoimmunity. Here, we demonstrate that mutation of the WAS gene results in B cells that are hyperresponsive to B cell receptor and Toll-like receptor (TLR) signals in vitro, thereby promoting a B cell–intrinsic break in tolerance. Whereas this defect leads to autoantibody production in WAS protein–deficient (WASp−/−) mice without overt disease, chimeric mice in which only the B cell lineage lacks WASp exhibit severe autoimmunity characterized by spontaneous germinal center formation, class-switched autoantibodies, renal histopathology, and early mortality. Both T cell help and B cell–intrinsic TLR engagement play important roles in promoting disease in this model, as depletion with anti-CD4 antibodies or generation of chimeric mice with B cells deficient in both WASp and MyD88 prevented development of autoimmune disease. These data highlight the potentially harmful role for cell-intrinsic loss of B cell tolerance in the setting of normal T cell function, and may explain why WAS patients with mixed chimerism after stem cell transplantation often develop severe humoral autoimmunity.
rupress.org